Meet information demands through modular content

Adopting a modular content strategy allows pharmaceutical companies to reuse and adapt information, speeding up content creation cycles without risking personalization.

Commercial

Genetika+: Transforming Digital Health with Precision Medicine Innovations

In an era defined by groundbreaking scientific advancements and a patient-centered approach to healthcare, Genetika+ emerges as a...

Commercial

Cracking the commercial code in digital health

Examining pharma’s track record in digital health recalls that famous BBC nature documentary in which hatchling marine iguanas must...

Latest

Access and Evidence
Transform patient-driven healthcare: Synthesize RWE and AI

Maria Aguirre G..., (Sep 7, 2023)

The future of healthcare is here, and it's powered by real-world evidence (RWE) and artificial intelligence (AI), transforming patient care and clinical decision-making.
Commercial
Genetika+: Transforming Digital Health with Precision Medicine Innovations

Maria Aguirre G..., (Sep 6, 2023)

Pioneering the field of precision medicine, Genetika+ employs state-of-the-art technology to transform extensive datasets into actionable insights, elevating patient outcomes and providing invaluable support to pharmaceutical companies
Medical
How to boost technology-driven decentralization in clinical trials

Maria Aguirre G..., (Sep 1, 2023)

Techniques that pharmaceutical companies can implement to be more effective in collecting non-traditional data and have a more complete view of a drug’s performance in clinical trials
Commercial
An omnichannel strategy is necessary to meet HCP needs

Maria Aguirre G..., (Aug 25, 2023)

HCP preferences have rapidly shifted towards remote and hybrid engagement. Cultural transformation, data silo elimination, and cross-functional collaboration are key to meeting these new demands through a successful omnichannel transition.
Commercial
Cracking the commercial code in digital health

Andrew Stone, (Aug 24, 2023)

Pharma must internalise some hard lessons if its future digital health solutions are to have a significant commercial impact

Opinion

Love and sacrifice: The Zena Sfeir Story

Jill Donahue, (Mar 16, 2023)

For Zena Sfeir, Aitia VP Marketing, a strong sense of purpose is key to making an impact and improving lives

Living a resilient life: The Ana Paula Carvalho story

Jill Donahue, (Sep 5, 2022)

For Ana Paula Carvalho, President of Western Europe Cluster, Pfizer, her purpose began amidst overcoming challenges.

More Columns

Commercial

Genetika+: Transforming Digital Health with Precision Medicine Innovations

Maria Aguirre G..., (Sep 6, 2023)

Pioneering the field of precision medicine, Genetika+ employs state-of-the-art technology to transform extensive datasets into actionable insights, elevating patient outcomes and providing invaluable support to pharmaceutical companies
An omnichannel strategy is necessary to meet HCP needs

Maria Aguirre G..., (Aug 25, 2023)

HCP preferences have rapidly shifted towards remote and hybrid engagement. Cultural transformation, data silo elimination, and cross-functional collaboration are key to meeting these new demands through a successful omnichannel transition.
Cracking the commercial code in digital health

Andrew Stone, (Aug 24, 2023)

Pharma must internalise some hard lessons if its future digital health solutions are to have a significant commercial impact
Pharma’s likely digital comms budget jump a blow for print channels

Maria Aguirre G..., (Jul 20, 2023)

Pharmaceutical companies are likely to go digital in the next three-to-four years even with return of in-person engagements
Optimize next best action tools to deliver value-based engagement

Maria Aguirre G..., (Jun 23, 2023)

Discover a 6-stage roadmap enabling pharmaceutical companies to achieve a true omnichannel engagement strategy while seamlessly integrating next-best-action (NBA) approaches

More Commercial

Access and Evidence

Transform patient-driven healthcare: Synthesize RWE and AI

Maria Aguirre G..., (Sep 7, 2023)

The future of healthcare is here, and it's powered by real-world evidence (RWE) and artificial intelligence (AI), transforming patient care and clinical decision-making.
How to develop out-of-the-box evidence collection strategies to boost approval rates

Maria Aguirre G..., (Aug 18, 2023)

Enhanced evidence collection methodologies can improve approval rates and ensure reimbursement. Pharma companies should build an internal, cross-functional evidence team responsible for investigating new ways to collect and report clinical trial data
RWE’s new dataset: Social media

Andrew Stone, (Nov 22, 2022)

Pharma is waking up to the potential of social media to enhance existing RWD sources and to offer altogether new insights in rare disease and beyond
How automation is changing regulatory affairs

Andrew Stone, (Apr 14, 2022)

Post pandemic, pharma and regulators are both working to accelerate the transformative power of electronic filing
An early peek at the FDA’s RWE ‘cookbook’

Andrew Stone, (Mar 10, 2022)

The FDA is developing guidelines that will help pharma accelerate its adoption of RWE, this is what the industry should know

More Market Access

Patients and Medical

Keep HCPs engaged via data insights and the human touch

Maria Aguirre G..., (Aug 11, 2023)

Personal expertise from field teams should be combined with data insights to successfully personalize engagements with HCPs and build trust.
Dismantling gender bias to optimize hemophilia care for women and girls

Maria Aguirre G..., (Jul 27, 2023)

Champion voices to raise awareness, eliminate disparities, and develop next best actions
Pharma should embrace its role as a trusted information source

Maria Aguirre G..., (Jul 12, 2023)

Patients are increasingly having to research their own health needs. Pharmaceutical companies can help fill in information gaps for patients to protect trust in the healthcare sector
Moving care from hospital to home

Andrew Stone, (May 16, 2023)

Innovation to enable care from the comfort of home is gathering momentum but implementing it in practice is complex
PED: Turning the patient voice into a dataset

Andrew Stone, (Apr 3, 2023)

Patients and pharma are teaming up to capture valuable patient experience data and they are only getting started

More Patients and Medical

Reuters Events | Pharma
Thought leadership and innovation for the Pharmaceutical Industry

Meet information demands through modular content

Genetika+: Transforming Digital Health with Precision Medicine Innovations

Cracking the commercial code in digital health

Latest

Transform patient-driven healthcare: Synthesize RWE and AI

Genetika+: Transforming Digital Health with Precision Medicine Innovations

How to boost technology-driven decentralization in clinical trials

An omnichannel strategy is necessary to meet HCP needs

Cracking the commercial code in digital health

Most Popular

Opinion

Commercial

Genetika+: Transforming Digital Health with Precision Medicine Innovations

An omnichannel strategy is necessary to meet HCP needs

Cracking the commercial code in digital health

Pharma’s likely digital comms budget jump a blow for print channels

Optimize next best action tools to deliver value-based engagement

Access and Evidence

Transform patient-driven healthcare: Synthesize RWE and AI

How to develop out-of-the-box evidence collection strategies to boost approval rates

RWE’s new dataset: Social media

How automation is changing regulatory affairs

An early peek at the FDA’s RWE ‘cookbook’

Patients and Medical

Keep HCPs engaged via data insights and the human touch

Dismantling gender bias to optimize hemophilia care for women and girls

Pharma should embrace its role as a trusted information source

Moving care from hospital to home

PED: Turning the patient voice into a dataset

Latest Videos

Reuters Newsmakers Interview with Dr. Albert Bourla, Pfizer's CEO

What is pharma doing about hybrid HCP engagement?

What are pharma industry leaders saying about hosted content?

How is pharma engaging with HCPs? Educational platforms and activities

How is pharma co-creating with HCPs?

Upcoming Events

October 2023

November 2023

In-Depth Analysis

Login

Latest

Most Popular

Opinion

Commercial

Access and Evidence

Patients and Medical

Latest Videos

Upcoming Events

October 2023

November 2023

In-Depth Analysis